Citigroup’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-41,471
Closed -$108K 4940
2023
Q3
$108K Buy
41,471
+4,027
+11% +$10.5K ﹤0.01% 3218
2023
Q2
$134K Buy
37,444
+12,388
+49% +$44.3K ﹤0.01% 3430
2023
Q1
$54.6K Sell
25,056
-40,834
-62% -$89K ﹤0.01% 3597
2022
Q4
$793K Buy
65,890
+35,246
+115% +$424K ﹤0.01% 2224
2022
Q3
$199K Buy
30,644
+27,061
+755% +$176K ﹤0.01% 3093
2022
Q2
$16K Buy
3,583
+1,138
+47% +$5.08K ﹤0.01% 4425
2022
Q1
$21K Sell
2,445
-5,839
-70% -$50.2K ﹤0.01% 4381
2021
Q4
$118K Buy
8,284
+4,839
+140% +$68.9K ﹤0.01% 3883
2021
Q3
$76K Buy
3,445
+74
+2% +$1.63K ﹤0.01% 3783
2021
Q2
$45K Sell
3,371
-621
-16% -$8.29K ﹤0.01% 4207
2021
Q1
$41K Sell
3,992
-4,708
-54% -$48.4K ﹤0.01% 4153
2020
Q4
$37K Hold
8,700
﹤0.01% 4274
2020
Q3
$23K Hold
8,700
﹤0.01% 3876
2020
Q2
$31K Hold
8,700
﹤0.01% 3984
2020
Q1
$26K Sell
8,700
-800
-8% -$2.39K ﹤0.01% 4219
2019
Q4
$49K Hold
9,500
﹤0.01% 3978
2019
Q3
$30K Hold
9,500
﹤0.01% 4039
2019
Q2
$34K Hold
9,500
﹤0.01% 4331
2019
Q1
$35K Hold
9,500
﹤0.01% 4249
2018
Q4
$29K Hold
9,500
﹤0.01% 4248
2018
Q3
$46K Buy
9,500
+2,100
+28% +$10.2K ﹤0.01% 4125
2018
Q2
$55K Buy
7,400
+855
+13% +$6.36K ﹤0.01% 3813
2018
Q1
$43K Buy
+6,545
New +$43K ﹤0.01% 3845
2016
Q1
Sell
-73
Closed -$1K 5520
2015
Q4
$1K Buy
+73
New +$1K ﹤0.01% 5265
2015
Q2
Sell
-115
Closed 5675
2015
Q1
$0 Buy
+115
New ﹤0.01% 5596
2014
Q4
Sell
-3,000
Closed -$24K 5560
2014
Q3
$24K Buy
3,000
+1,000
+50% +$8K ﹤0.01% 4160
2014
Q2
$19K Buy
2,000
+1,000
+100% +$9.5K ﹤0.01% 4210
2014
Q1
$12K Buy
1,000
+700
+233% +$8.4K ﹤0.01% 4725
2013
Q4
$5K Buy
+300
New +$5K ﹤0.01% 5011